Software - Application
Compare Stocks
5 / 10Stock Comparison
GWRE vs SPNS vs NOW vs ORCL vs PEGA
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Software - Application
Software - Infrastructure
Software - Application
GWRE vs SPNS vs NOW vs ORCL vs PEGA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Software - Application | Software - Application | Software - Infrastructure | Software - Application |
| Market Cap | $11.70B | $2.43B | $94.48B | $563.33B | $6.08B |
| Revenue (TTM) | $1.34B | $564M | $13.96B | $64.08B | $1.70B |
| Net Income (TTM) | $189M | $64M | $1.76B | $16.21B | $341M |
| Gross Margin | 63.8% | 44.3% | 76.6% | 66.4% | 75.0% |
| Operating Margin | 6.8% | 13.7% | 13.4% | 30.8% | 10.2% |
| Forward P/E | 39.4x | 27.9x | 21.9x | 26.2x | 13.2x |
| Total Debt | $716M | $64M | $3.20B | $104.10B | $76M |
| Cash & Equiv. | $699M | $164M | $3.73B | $10.79B | $212M |
GWRE vs SPNS vs NOW vs ORCL vs PEGA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Guidewire Software,… (GWRE) | 100 | 135.0 | +35.0% |
| Sapiens Internation… (SPNS) | 100 | 184.0 | +84.0% |
| ServiceNow, Inc. (NOW) | 100 | 23.5 | -76.5% |
| Oracle Corporation (ORCL) | 100 | 364.4 | +264.4% |
| Pegasystems Inc. (PEGA) | 100 | 75.6 | -24.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GWRE vs SPNS vs NOW vs ORCL vs PEGA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GWRE ranks third and is worth considering specifically for growth exposure.
- Rev growth 22.6%, EPS growth 11.9%, 3Y rev CAGR 14.0%
- 22.6% revenue growth vs SPNS's 5.4%
SPNS carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 0.45, yield 1.3%
- Lower volatility, beta 0.45, Low D/E 13.3%, current ratio 2.24x
- Beta 0.45, yield 1.3%, current ratio 2.24x
- Beta 0.45 vs ORCL's 1.58, lower leverage
NOW is the clearest fit if your priority is valuation efficiency.
- PEG 0.32 vs ORCL's 3.69
ORCL is the clearest fit if your priority is long-term compounding.
- 428.7% 10Y total return vs SPNS's 301.1%
- 25.3% margin vs SPNS's 11.4%
PEGA is the #2 pick in this set and the best alternative if value and efficiency is your priority.
- Lower P/E (13.2x vs 26.2x)
- 23.5% ROA vs GWRE's 7.2%, ROIC 27.2% vs 2.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 22.6% revenue growth vs SPNS's 5.4% | |
| Value | Lower P/E (13.2x vs 26.2x) | |
| Quality / Margins | 25.3% margin vs SPNS's 11.4% | |
| Stability / Safety | Beta 0.45 vs ORCL's 1.58, lower leverage | |
| Dividends | 1.3% yield, 1-year raise streak, vs ORCL's 0.8%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +53.4% vs NOW's -90.6% | |
| Efficiency (ROA) | 23.5% ROA vs GWRE's 7.2%, ROIC 27.2% vs 2.3% |
GWRE vs SPNS vs NOW vs ORCL vs PEGA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
GWRE vs SPNS vs NOW vs ORCL vs PEGA — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PEGA leads in 2 of 6 categories
ORCL leads 1 • SPNS leads 1 • GWRE leads 0 • NOW leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — GWRE and NOW and ORCL each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ORCL is the larger business by revenue, generating $64.1B annually — 113.5x SPNS's $564M. ORCL is the more profitable business, keeping 25.3% of every revenue dollar as net income compared to SPNS's 11.4%. On growth, GWRE holds the edge at +24.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.3B | $564M | $14.0B | $64.1B | $1.7B |
| EBITDAEarnings before interest/tax | $103M | $93M | $2.7B | $26.5B | $193M |
| Net IncomeAfter-tax profit | $189M | $64M | $1.8B | $16.2B | $341M |
| Free Cash FlowCash after capex | $310M | $72M | $4.6B | -$24.7B | $495M |
| Gross MarginGross profit ÷ Revenue | +63.8% | +44.3% | +76.6% | +66.4% | +75.0% |
| Operating MarginEBIT ÷ Revenue | +6.8% | +13.7% | +13.4% | +30.8% | +10.2% |
| Net MarginNet income ÷ Revenue | +14.1% | +11.4% | +12.6% | +25.3% | +20.0% |
| FCF MarginFCF ÷ Revenue | +23.1% | +12.8% | +33.2% | -38.6% | +29.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +24.0% | +11.2% | +22.1% | +21.7% | -9.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.6% | -24.2% | +2.3% | +24.5% | -60.0% |
Valuation Metrics
PEGA leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 16.9x trailing earnings, PEGA trades at a 90% valuation discount to GWRE's 170.9x P/E. Adjusting for growth (PEG ratio), NOW offers better value at 0.79x vs ORCL's 6.36x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $11.7B | $2.4B | $94.5B | $563.3B | $6.1B |
| Enterprise ValueMkt cap + debt − cash | $11.7B | $2.3B | $94.0B | $656.6B | $5.9B |
| Trailing P/EPrice ÷ TTM EPS | 170.93x | 33.68x | 54.60x | 45.15x | 16.89x |
| Forward P/EPrice ÷ next-FY EPS est. | 39.38x | 27.85x | 21.94x | 26.18x | 13.23x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.69x | 0.79x | 6.36x | — |
| EV / EBITDAEnterprise value multiple | 180.79x | 22.11x | 36.67x | 27.53x | 20.57x |
| Price / SalesMarket cap ÷ Revenue | 9.73x | 4.48x | 7.12x | 9.81x | 3.48x |
| Price / BookPrice ÷ Book value/share | 8.16x | 5.09x | 7.36x | 26.78x | 8.44x |
| Price / FCFMarket cap ÷ FCF | 39.66x | 33.63x | 20.65x | — | 12.39x |
Profitability & Efficiency
PEGA leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ORCL delivers a 56.3% return on equity — every $100 of shareholder capital generates $56 in annual profit, vs $13 for SPNS. PEGA carries lower financial leverage with a 0.10x debt-to-equity ratio, signaling a more conservative balance sheet compared to ORCL's 4.96x. On the Piotroski fundamental quality scale (0–9), SPNS scores 8/9 vs NOW's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +12.9% | +12.9% | +15.0% | +56.3% | +50.2% |
| ROA (TTM)Return on assets | +7.2% | +8.9% | +7.5% | +8.1% | +23.5% |
| ROICReturn on invested capital | +2.3% | +17.4% | +12.4% | +12.8% | +27.2% |
| ROCEReturn on capital employed | +2.3% | +16.9% | +13.2% | +14.4% | +33.4% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 8 | 3 | 6 | 8 |
| Debt / EquityFinancial leverage | 0.49x | 0.13x | 0.25x | 4.96x | 0.10x |
| Net DebtTotal debt minus cash | $17M | -$100M | -$523M | $93.3B | -$136M |
| Cash & Equiv.Liquid assets | $699M | $164M | $3.7B | $10.8B | $212M |
| Total DebtShort + long-term debt | $716M | $64M | $3.2B | $104.1B | $76M |
| Interest CoverageEBIT ÷ Interest expense | 388.85x | 228.41x | 185.08x | 5.44x | 643.17x |
Total Returns (Dividends Reinvested)
ORCL leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ORCL five years ago would be worth $25,437 today (with dividends reinvested), compared to $1,953 for NOW. Over the past 12 months, SPNS leads with a +53.4% total return vs NOW's -90.6%. The 3-year compound annual growth rate (CAGR) favors ORCL at 27.6% vs NOW's -40.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -26.2% | — | -38.2% | +0.6% | -35.7% |
| 1-Year ReturnPast 12 months | -35.1% | +53.4% | -90.6% | +31.7% | -23.2% |
| 3-Year ReturnCumulative with dividends | +78.2% | +100.9% | -79.2% | +107.9% | +65.1% |
| 5-Year ReturnCumulative with dividends | +41.7% | +64.0% | -80.5% | +154.4% | -38.6% |
| 10-Year ReturnCumulative with dividends | +149.8% | +301.1% | +35.2% | +428.7% | +182.9% |
| CAGR (3Y)Annualised 3-year return | +21.2% | +26.2% | -40.8% | +27.6% | +18.2% |
Risk & Volatility
SPNS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SPNS is the less volatile stock with a 0.45 beta — it tends to amplify market swings less than ORCL's 1.58 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SPNS currently trades 99.8% from its 52-week high vs NOW's 8.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.50x | 0.45x | 1.39x | 1.58x | 1.12x |
| 52-Week HighHighest price in past year | $272.60 | $43.52 | $1057.39 | $345.72 | $68.10 |
| 52-Week LowLowest price in past year | $115.57 | $26.14 | $81.24 | $134.57 | $34.34 |
| % of 52W HighCurrent price vs 52-week peak | +50.8% | +99.8% | +8.6% | +56.7% | +52.8% |
| RSI (14)Momentum oscillator 0–100 | 49.7 | 69.6 | 48.0 | 68.7 | 40.5 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 0 | 21.1M | 26.3M | 2.2M |
Analyst Outlook
Evenly matched — SPNS and ORCL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: GWRE as "Buy", SPNS as "Hold", NOW as "Buy", ORCL as "Buy", PEGA as "Buy". Consensus price targets imply 77.1% upside for GWRE (target: $245) vs -12.5% for SPNS (target: $38). For income investors, SPNS offers the higher dividend yield at 1.30% vs PEGA's 0.23%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $245.17 | $38.00 | $154.08 | $257.09 | $56.60 |
| # AnalystsCovering analysts | 26 | 10 | 68 | 86 | 23 |
| Dividend YieldAnnual dividend ÷ price | — | +1.3% | — | +0.8% | +0.2% |
| Dividend StreakConsecutive years of raises | — | 1 | — | 18 | 1 |
| Dividend / ShareAnnual DPS | — | $0.57 | — | $1.65 | $0.08 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +1.9% | +0.3% | +8.5% |
PEGA leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). ORCL leads in 1 (Total Returns). 2 tied.
GWRE vs SPNS vs NOW vs ORCL vs PEGA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GWRE or SPNS or NOW or ORCL or PEGA a better buy right now?
For growth investors, Guidewire Software, Inc.
(GWRE) is the stronger pick with 22. 6% revenue growth year-over-year, versus 5. 4% for Sapiens International Corporation N. V. (SPNS). Pegasystems Inc. (PEGA) offers the better valuation at 16. 9x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate Guidewire Software, Inc. (GWRE) a "Buy" — based on 26 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GWRE or SPNS or NOW or ORCL or PEGA?
On trailing P/E, Pegasystems Inc.
(PEGA) is the cheapest at 16. 9x versus Guidewire Software, Inc. at 170. 9x. On forward P/E, Pegasystems Inc. is actually cheaper at 13. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ServiceNow, Inc. wins at 0. 32x versus Oracle Corporation's 3. 69x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — GWRE or SPNS or NOW or ORCL or PEGA?
Over the past 5 years, Oracle Corporation (ORCL) delivered a total return of +154.
4%, compared to -80. 5% for ServiceNow, Inc. (NOW). Over 10 years, the gap is even starker: ORCL returned +428. 7% versus NOW's +35. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GWRE or SPNS or NOW or ORCL or PEGA?
By beta (market sensitivity over 5 years), Sapiens International Corporation N.
V. (SPNS) is the lower-risk stock at 0. 45β versus Oracle Corporation's 1. 58β — meaning ORCL is approximately 248% more volatile than SPNS relative to the S&P 500. On balance sheet safety, Pegasystems Inc. (PEGA) carries a lower debt/equity ratio of 10% versus 5% for Oracle Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — GWRE or SPNS or NOW or ORCL or PEGA?
By revenue growth (latest reported year), Guidewire Software, Inc.
(GWRE) is pulling ahead at 22. 6% versus 5. 4% for Sapiens International Corporation N. V. (SPNS). On earnings-per-share growth, the picture is similar: Guidewire Software, Inc. grew EPS 1192% year-over-year, compared to 15. 2% for Sapiens International Corporation N. V.. Over a 3-year CAGR, NOW leads at 22. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GWRE or SPNS or NOW or ORCL or PEGA?
Pegasystems Inc.
(PEGA) is the more profitable company, earning 22. 5% net margin versus 5. 8% for Guidewire Software, Inc. — meaning it keeps 22. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ORCL leads at 30. 8% versus 3. 4% for GWRE. At the gross margin level — before operating expenses — NOW leads at 77. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GWRE or SPNS or NOW or ORCL or PEGA more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ServiceNow, Inc. (NOW) is the more undervalued stock at a PEG of 0. 32x versus Oracle Corporation's 3. 69x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Pegasystems Inc. (PEGA) trades at 13. 2x forward P/E versus 39. 4x for Guidewire Software, Inc. — 26. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GWRE: 77. 1% to $245. 17.
08Which pays a better dividend — GWRE or SPNS or NOW or ORCL or PEGA?
In this comparison, SPNS (1.
3% yield), ORCL (0. 8% yield), PEGA (0. 2% yield) pay a dividend. GWRE, NOW do not pay a meaningful dividend and should not be held primarily for income.
09Is GWRE or SPNS or NOW or ORCL or PEGA better for a retirement portfolio?
For long-horizon retirement investors, Sapiens International Corporation N.
V. (SPNS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 45), 1. 3% yield, +301. 1% 10Y return). Both have compounded well over 10 years (SPNS: +301. 1%, NOW: +35. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GWRE and SPNS and NOW and ORCL and PEGA?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: GWRE is a mid-cap high-growth stock; SPNS is a small-cap quality compounder stock; NOW is a mid-cap high-growth stock; ORCL is a large-cap quality compounder stock; PEGA is a small-cap high-growth stock. SPNS, ORCL pay a dividend while GWRE, NOW, PEGA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.